arrow
S

Stephen-John Sammut

Institute of Cancer Research
H指数:28
被引数:7,936

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells

通过整合免疫细胞、基质细胞和肿瘤细胞的去卷积表达模式,增强对乳腺癌患者化疗反应的预测

2025-10-300
PRE
Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition

肿瘤相关中性粒细胞前体损害同源DNA修复并促进对PARP抑制的敏感性

2025-07-300
OA
Fitness and transcriptional plasticity of human breast cancer single-cell-derived clones

人类乳腺癌单细胞来源克隆的适应性及转录组可塑性

2025-05-010
OA
A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival

一项针对转移性乳腺癌患者的大规模回顾性研究,采用循环肿瘤DNA和机器学习方法来预测治疗效果和无进展生存期。

2025-04-150
OAAI
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer
2025-02-130
OA
Quantifying the tumour vasculature environment from CD-31 immunohistochemistry images of breast cancer using deep learning based semantic segmentation

使用基于深度学习的语义分割从乳腺癌的CD-31免疫组织化学图像量化肿瘤脉管系统环境

2025-02-040
OAAI
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics

一种深度学习框架,通过转录组学预测组织病理学图像的癌症治疗反应

2024-07-035
OA
Comparison of tumor-informed and tumor-naive sequencing assays for ctDNA detection in breast cancer

用于乳腺癌中ctDNA检测的肿瘤知情和未肿瘤测序分析的比较

2023-05-109
OAAI
AACR Project GENIE: 100,000 Cases and Beyond

AACR项目精灵: 100,000个案例及以后

2022-07-1239
OAAI
Multi-omic machine learning predictor of breast cancer therapy response

乳腺癌治疗反应的多组学机器学习预测器

Nature
IF48.5
2021-12-070
OAAI
DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation

1538乳腺癌的DNA甲基化景观揭示了与复制相关的时钟,表观基因组不稳定性和顺式调节

2021-09-1332
OAAI
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

HER2-negative原发性乳腺癌的时间突变和免疫肿瘤微环境重塑

2021-06-075
OAAI
Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer: A multi-center pooled analysis
2020-02-1513
PRE